Cargando…
Prescriptions for Codeine or Hydrocodone Cough and Cold Medications to US Children and Adolescents Following US Food and Drug Administration Safety Communications
This cross-sectional study uses national prescription data to assess whether safety communications from the US Food and Drug Administration (FDA) issued in 2017 and 2018 were associated with changes in prescriptions for codeine and hydrocodone cough and cold medications to children and adolescents.
Autores principales: | Chua, Kao-Ping, Conti, Rena M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586901/ https://www.ncbi.nlm.nih.gov/pubmed/34762115 http://dx.doi.org/10.1001/jamanetworkopen.2021.34142 |
Ejemplares similares
-
Effectiveness and Safety of Codeine and Levodropropizine in Patients With Chronic Cough
por: Lee, Sang Pyo, et al.
Publicado: (2022) -
A Benefit Risk Review of Pediatric Use of Hydrocodone/Chlorpheniramine, a Prescription Opioid Antitussive Agent for the Treatment of Cough
por: Sloan, Victor S., et al.
Publicado: (2019) -
The Decline in Hydrocodone/Acetaminophen Prescriptions in Emergency Departments in the Veterans Health Administration Between 2009 to 2015
por: Grasso, Michael A., et al.
Publicado: (2016) -
Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone
por: Ben-Joseph, Rami, et al.
Publicado: (2016) -
U.S. Pharmacist Opinions Regarding the Rescheduling of Hydrocodone Combination Products: A Pilot Study
por: Covvey, Jordan R., et al.
Publicado: (2015)